TickerFacts.

Insulet Corp (PODD): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2014-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$564.20M
Year ended 2025-12-31
$615.00M
Trailing 12 months to 2026-06-30
+77.6%
3-year compound annual growth
+39.5%
5-year compound annual growth
2009-12-31: -$54.14M2010-12-31: -$33.56M2011-12-31: -$33.96M2012-12-31: -$24.94M2013-12-31: -$17.33M2014-12-31: $3.35M2015-12-31: -$32.90M2016-12-31: $3.13M2017-12-31: $6.50M2018-12-31: $43.00M2019-12-31: $77.90M2020-12-31: $106.90M2021-12-31: $183.40M2022-12-31: $100.80M2023-12-31: $292.90M2024-12-31: $389.70M2025-12-31: $564.20M$564.20M
2009-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$564.20M+44.8%2026-02-18, From 2025-01-01
2024-12-31$389.70M+33.0%2026-02-18, From 2024-01-01
2023-12-31$292.90M+190.6%2026-02-18, From 2023-01-01
2022-12-31$100.80M-45.0%2025-02-21, From 2022-01-01
2021-12-31$183.40M+71.6%2024-02-23, From 2021-01-01
2020-12-31$106.90M+37.2%2023-02-24, From 2020-01-01
2019-12-31$77.90M+81.2%2022-02-24, From 2019-01-01
2018-12-31$43.00M+561.5%2021-02-24, From 2018-01-01
2017-12-31$6.50M+107.7%2020-02-26, From 2017-01-01
2016-12-31$3.13Mn/m2019-02-26, From 2016-01-01
2015-12-31-$32.90Mn/m2018-02-22, From 2015-01-01
2014-12-31$3.35Mn/c2017-02-28, From 2014-01-01
2013-12-31-$17.33Mn/m2016-02-29, From 2013-01-01
2012-12-31-$24.94Mn/m2015-02-26, From 2012-01-01
2011-12-31-$33.96Mn/m2014-02-28, From 2011-01-01
2010-12-31-$33.56Mn/m2013-02-28, From 2010-01-01
2009-12-31-$54.14Mn/a2013-02-28, From 2009-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Insulet Corp (PODD)2025-12-31$564.20M+44.8%
Globus Medical Inc (GMED)2025-12-31$756.66M+80.4%
West Pharmaceutical Services Inc (WST)2025-12-31$756.30M+4.3%
MiniMed Group, Inc. (MMED)2026-04-24-$34.00Mn/m
ICU Medical Inc (ICUI)2025-12-31$243.57M-7.2%
Teleflex Inc (TFX)2025-12-31$296.11M+11.7%
Dexcom Inc (DXCM)2025-12-31$1.16B+42.3%
Merit Medical Systems Inc (MMSI)2025-12-31$307.89M+19.2%
Penumbra Inc (PEN)2025-12-31$206.72M+526.8%

Compare PODD, GMED, WST, MMED side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗